REGN vs TCNNF · P/E 14, rev $4.29B vs rev $1.19B
Regeneron Pharmaceuticals Inc (REGN) versus Trulieve Cannabis Corp (TCNNF) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Trulieve Cannabis Corp (TCNNF) common stock listed on OTCQX.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TCNNF revenue for 2024-12-31 was $1.19B. Net income was -$160.6M. Revenue was up 5.1% from 2023-12-31 to 2024-12-31. TCNNF currently screens at market cap $1.82B.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TCNNF currently screens at market cap $1.82B.
Not investment advice. Open the REGN and TCNNF stock pages for the full models.
Not investment advice.